Serplulimab for Locally Advanced Cervical Cancer

NCT07340489 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

216

Enrollment

OTHER

Sponsor class

Conditions

Cervical Cancer

Interventions

DRUG: Serplulimab
RADIATION: radiotherapy
DRUG: Chemotherapy

Sponsor

Tianjin Medical University Cancer Institute and Hospital